Clinical utility of ustekinumab in Crohn’s disease

The introduction of anti-tumor necrosis factor (TNF) therapy marked an important milestone in the management of moderate-to-severe Crohn’s disease (CD). However, there remains a pressing demand for alternative therapeutic options for patients with primary nonresponse, secondary loss of response, or...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Inflamm Res
Main Authors: Kotze, Paulo Gustavo, Ma, Christopher, Almutairdi, Abdulelah, Panaccione, Remo
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2018
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5810512/
https://ncbi.nlm.nih.gov/pubmed/29445293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JIR.S157358
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker